Entities / Company
Astro-Med (United States).
company in West Warwick, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 39
What's happening
Gone quiet
No new reports in 90+ days-
Samir Patel initiated a proxy contest against AstroNova, which is linked to the corporate challenges faced by Astro-Med (US).Speculative2 reports1 development inside
-
Board claims to share Samir Patel's concerns regarding corporate challenges at Astro-Med (US).Speculative1 report
-
AstroNova addressed challenges of the MTEX acquisition and promoted Jorik E. Ittmann and Padraig Finn in August 2025.Some support1 report2 developments inside
-
The MTEX transaction caused shareholder value destruction, leading to calls for board changes supported by the International Institute of Social Studies.Speculative1 report
-
Greg Woods resigned as CEO of AstroNova on July 1, 2025, causing shares to soar and drawing criticism from Glass Lewis.Speculative2 reports
-
AstroNova's Return on Capital Employed (ROCE) underperformed the industry average in July 2025.Some support1 report
-
Astro-Med's share price performance lagged the overall market return on August 14, 2025.Some support1 report
-
Shawn Kravetz was appointed to AstroNova's board of directors after being nominated by Askeladden Capital Management LLC.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Connections
The 3 strongest of 39, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MTEX Structural
AstroNova acquired MTEX and integrated its technology into its product line, creating a dependent parent-subsidiary relationship.
-
Samir Patel Operational
Samir Patel, a major shareholder, is engaged in active governance conflict and proxy contests against Astro-Med.
-
Greg Woods Mentioned together
The provided evidence does not contain any information linking Astro-Med and Greg Woods.
History
Events by the month they beganJune 2026
8 events- Samir Patel initiated a proxy contest against AstroNova, which is linked to the corporate challenges faced by Astro-Med (US).
- Board claims to share Samir Patel's concerns regarding corporate challenges at Astro-Med (US).
- AstroNova addressed challenges of the MTEX acquisition and promoted Jorik E. Ittmann and Padraig Finn in August 2025.
- The MTEX transaction caused shareholder value destruction, leading to calls for board changes supported by the International Institute of Social Studies.
- Greg Woods resigned as CEO of AstroNova on July 1, 2025, causing shares to soar and drawing criticism from Glass Lewis.
- AstroNova's Return on Capital Employed (ROCE) underperformed the industry average in July 2025.
- Astro-Med's share price performance lagged the overall market return on August 14, 2025.
- Shawn Kravetz was appointed to AstroNova's board of directors after being nominated by Askeladden Capital Management LLC.